These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 19530743)

  • 1. Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.
    Schlatter C; Egger SS; Tchambaz L; Krähenbühl S
    Drug Saf; 2009; 32(7):561-78. PubMed ID: 19530743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of antidepressants in patients with hepatic impairment.
    Mauri MC; Fiorentini A; Paletta S; Altamura AC
    Clin Pharmacokinet; 2014 Dec; 53(12):1069-81. PubMed ID: 25248846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose adjustment in patients with liver disease.
    Delcò F; Tchambaz L; Schlienger R; Drewe J; Krähenbühl S
    Drug Saf; 2005; 28(6):529-45. PubMed ID: 15924505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(12):761-804. PubMed ID: 19902987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose adaptation of antineoplastic drugs in patients with liver disease.
    Tchambaz L; Schlatter C; Jakob M; Krähenbühl A; Wolf P; Krähenbühl S
    Drug Saf; 2006; 29(6):509-22. PubMed ID: 16752933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of hepatic cytochrome P450 enzymes for psychopharmacology].
    Normann C; Hesslinger B; Bauer J; Berger M; Walden J
    Nervenarzt; 1998 Nov; 69(11):944-55. PubMed ID: 9859115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic medications and cytochrome P450 2D6: pharmacokinetic considerations in the elderly.
    Shulman RW; Ozdemir V
    Can J Psychiatry; 1997 Jun; 42 Suppl 1():4S-9S. PubMed ID: 9220124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.
    Verbeeck RK
    Eur J Clin Pharmacol; 2008 Dec; 64(12):1147-61. PubMed ID: 18762933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prescription of psychotropic drugs in paediatry: approved indications and therapeutic perspectives].
    Dumortier G; Welniarz B; Sauvebois C; Medjdoub H; Friche H; Siad N; Degrassat K
    Encephale; 2005; 31(4 Pt 1):477-89. PubMed ID: 16389715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychopharmacotherapy of the elderly].
    Wollmer MA; Müller-Spahn F
    Ther Umsch; 2009 Jun; 66(6):459-65. PubMed ID: 19496042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of pharmacogenetics in psychiatry].
    Skrętkowicz J; Barańska M; Rychlik-Sych M
    Wiad Lek; 2013; 66(2 Pt 2):185-91. PubMed ID: 25775815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug interactions of psychotropic drugs].
    Sawada Y; Satoh H
    Nihon Rinsho; 2012 Jan; 70(1):27-41. PubMed ID: 22413489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between anticonvulsant and psychoactive drugs.
    Monaco F; Cicolin A
    Epilepsia; 1999; 40 Suppl 10():S71-6. PubMed ID: 10609607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic changes of drugs in a rat model of liver cirrhosis induced by dimethylnitrosamine, alone and in combination with diabetes mellitus induced by streptozotocin.
    Lee U; Oh E
    Biopharm Drug Dispos; 2015 Jan; 36(1):1-14. PubMed ID: 24861008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of psychotropic drugs in special populations.
    Rudorfer MV
    J Clin Psychiatry; 1993 Sep; 54 Suppl():50-4; discussion 55-6. PubMed ID: 8407858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of human hepatic cytochrome p450 isoforms to the metabolism of psychotropic drugs.
    Niwa T; Shiraga T; Ishii I; Kagayama A; Takagi A
    Biol Pharm Bull; 2005 Sep; 28(9):1711-6. PubMed ID: 16141545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of cytochrome P450 3A in psychopharmacology.
    Ketter TA; Flockhart DA; Post RM; Denicoff K; Pazzaglia PJ; Marangell LB; George MS; Callahan AM
    J Clin Psychopharmacol; 1995 Dec; 15(6):387-98. PubMed ID: 8748427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims Database.
    Hirano Y; Ii Y
    Clin Drug Investig; 2019 Nov; 39(11):1077-1092. PubMed ID: 31399894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacologic interactions of antibiotics and psychotropic drugs].
    Joos AA
    Psychiatr Prax; 1998 Mar; 25(2):57-60. PubMed ID: 9577846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology.
    Catterson ML; Preskorn SH; Martin RL
    Psychiatr Clin North Am; 1997 Mar; 20(1):205-18. PubMed ID: 9139291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.